BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16224052)

  • 1. Mechanisms of increased vascular superoxide production in an experimental model of idiopathic dilated cardiomyopathy.
    Mollnau H; Oelze M; August M; Wendt M; Daiber A; Schulz E; Baldus S; Kleschyov AL; Materne A; Wenzel P; Hink U; Nickenig G; Fleming I; Münzel T
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2554-9. PubMed ID: 16224052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling.
    Mollnau H; Wendt M; Szöcs K; Lassègue B; Schulz E; Oelze M; Li H; Bodenschatz M; August M; Kleschyov AL; Tsilimingas N; Walter U; Förstermann U; Meinertz T; Griendling K; Münzel T
    Circ Res; 2002 Mar; 90(4):E58-65. PubMed ID: 11884382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
    Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
    Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NADPH oxidase accounts for enhanced superoxide production and impaired endothelium-dependent smooth muscle relaxation in BKbeta1-/- mice.
    Oelze M; Warnholtz A; Faulhaber J; Wenzel P; Kleschyov AL; Coldewey M; Hink U; Pongs O; Fleming I; Wassmann S; Meinertz T; Ehmke H; Daiber A; Münzel T
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1753-9. PubMed ID: 16763163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guanylyl cyclase activator ataciguat improves vascular function and reduces platelet activation in heart failure.
    Schäfer A; Fraccarollo D; Werner L; Bauersachs J
    Pharmacol Res; 2010 Nov; 62(5):432-8. PubMed ID: 20600916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells.
    Mollnau H; Schulz E; Daiber A; Baldus S; Oelze M; August M; Wendt M; Walter U; Geiger C; Agrawal R; Kleschyov AL; Meinertz T; Münzel T
    Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):615-21. PubMed ID: 12692005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of diabetes on the expression of the gp91phox homologues nox1 and nox4.
    Wendt MC; Daiber A; Kleschyov AL; Mülsch A; Sydow K; Schulz E; Chen K; Keaney JF; Lassègue B; Walter U; Griendling KK; Münzel T
    Free Radic Biol Med; 2005 Aug; 39(3):381-91. PubMed ID: 15993337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase.
    Münzel T; Daiber A; Ullrich V; Mülsch A
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1551-7. PubMed ID: 15879305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats.
    Oelze M; Daiber A; Brandes RP; Hortmann M; Wenzel P; Hink U; Schulz E; Mollnau H; von Sandersleben A; Kleschyov AL; Mülsch A; Li H; Förstermann U; Münzel T
    Hypertension; 2006 Oct; 48(4):677-84. PubMed ID: 16940222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension.
    Schulz E; Jansen T; Wenzel P; Daiber A; Münzel T
    Antioxid Redox Signal; 2008 Jun; 10(6):1115-26. PubMed ID: 18321209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic high pressure-induced arterial oxidative stress: involvement of protein kinase C-dependent NAD(P)H oxidase and local renin-angiotensin system.
    Ungvari Z; Csiszar A; Kaminski PM; Wolin MS; Koller A
    Am J Pathol; 2004 Jul; 165(1):219-26. PubMed ID: 15215177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NO and PGI(2) in coronary endothelial dysfunction in transgenic mice with dilated cardiomyopathy.
    Drelicharz L; Kozlovski V; Skorka T; Heinze-Paluchowska S; Jasinski A; Gebska A; Guzik T; Olszanecki R; Wojnar L; Mende U; Csanyi G; Chlopicki S
    Basic Res Cardiol; 2008 Sep; 103(5):417-30. PubMed ID: 18431525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress.
    Suda O; Tsutsui M; Morishita T; Tasaki H; Ueno S; Nakata S; Tsujimoto T; Toyohira Y; Hayashida Y; Sasaguri Y; Ueta Y; Nakashima Y; Yanagihara N
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1682-8. PubMed ID: 15217805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II-dependent vascular alterations in young cardiomyopathic hamsters: role for oxidative stress.
    Escobales N; Crespo MJ
    Vascul Pharmacol; 2006 Jan; 44(1):22-8. PubMed ID: 16301003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB.
    Onozato ML; Tojo A; Goto A; Fujita T; Wilcox CS
    Kidney Int; 2002 Jan; 61(1):186-94. PubMed ID: 11786100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial dysfunction and superoxide anion production in heart failure are p38 MAP kinase-dependent.
    Widder J; Behr T; Fraccarollo D; Hu K; Galuppo P; Tas P; Angermann CE; Ertl G; Bauersachs J
    Cardiovasc Res; 2004 Jul; 63(1):161-7. PubMed ID: 15194473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: role of vascular superoxide anion formation and endothelial nitric oxide synthase expression.
    Bauersachs J; Heck M; Fraccarollo D; Hildemann SK; Ertl G; Wehling M; Christ M
    J Am Coll Cardiol; 2002 Jan; 39(2):351-8. PubMed ID: 11788231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-4-ylamine (BAY 41-2272) on smooth muscle tone, soluble guanylyl cyclase activity, and NADPH oxidase activity/expression in corpus cavernosum from wild-type, neuronal, and endothelial nitric-oxide synthase null mice.
    Teixeira CE; Priviero FB; Webb RC
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1093-102. PubMed ID: 17596536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet nitric oxide signalling in heart failure: role of oxidative stress.
    Shah A; Passacquale G; Gkaliagkousi E; Ritter J; Ferro A
    Cardiovasc Res; 2011 Sep; 91(4):625-31. PubMed ID: 21502370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of platelet activation in congestive heart failure by aldosterone receptor antagonism and ACE inhibition.
    Schäfer A; Fraccarollo D; Hildemann S; Christ M; Eigenthaler M; Kobsar A; Walter U; Bauersachs J
    Thromb Haemost; 2003 Jun; 89(6):1024-30. PubMed ID: 12783115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.